Projects per year
Organization profile
Organisation profile
The TMU Research Center of Cancer Translational Medicine (RCCTM) is established through combining all cancer-related resources of TMU and its three affiliated hospitals. RCCTM is established with the goal of translating the research discoveries into state-of-the-art therapeutics for the prevention and treatment of cancer, as well as training future oncologists. We are committed to reduce the cancer burden through skilled, integrated and compassionate clinical care, and to eliminate the threat of cancer through research and education.
Fingerprint Dive into the research topics where TMU Research Center of Cancer Translational Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Neoplasms
Medicine & Life Sciences
Taiwan
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Meta-Analysis
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Cells
Chemical Compounds
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Tze-Sian Chan
- Taipei Municipal Wanfang Hospital
- TMU Research Center of Cancer Translational Medicine
- Division of Gastroenterology and Hepatology
Person: Researcher
Projects 2011 2019
- 497 Finished
Long noncoding RNA在Dicer調控之micro-RNA重新編程的角色與sorafenib在肝癌中產生抗藥性的研究探討
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
探討小分子核糖核酸和腸道微生物在中風後血管性認知功能障礙所扮演的角色(1/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
核糖核?酸還原?在骨骼肌老化過程中所扮演的角色：RRM2B於修復與再生上的功能分析(3/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 1958 2019
2
Citations
(Scopus)
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase
Lai, M. J., Ojha, R., Lin, M. H., Liu, Y. M., Lee, H. Y., Lin, T. E., Hsu, K. C., Chang, C. Y., Chen, M. C., Nepali, K., Chang, J. Y. & Liou, J. P., Jan 15 2019, In : European Journal of Medicinal Chemistry. 162, p. 612-630 19 p.Research output: Contribution to journal › Article
Benzamides
Histone Deacetylases
Tubulin
Heterografts
Inhibitory Concentration 50
Activation of PERK in ET-1- and thrombin-induced pulmonary fibroblast differentiation: Inhibitory effects of curcumin
Chen, Y. C., Chen, B. C., Huang, H. M., Lin, S. H. & Lin, C-H., Jan 1 2019, In : Journal of Cellular Physiology.Research output: Contribution to journal › Article
Curcumin
Endothelin-1
Fibroblasts
Thrombin
Phosphotransferases
Adipose-derived Stem Cells Attenuates Diabetic Osteoarthritis via Inhibition of Glycation-mediated Inflammatory Cascade
Dubey, N. K., Wei, H-J., Yu, S. H., Williams, D. F., Wang, J. R., Deng, Y. H., Tsai, F. C., Wang, D. P. & Deng, W-P., 2019, In : Aging and Disease.Research output: Contribution to journal › Article
Osteoarthritis
Stem Cells
Knee Joint
Advanced Glycosylation End Products
NF-kappa B
Press / Media
2019 NTU Art Festival: “L’imagination au pouvoir”
7/8/19
1 item of media coverage
Press/Media: Press / Media
Fulgent Genetics CFO Paul Kim's value of investment increases by $219,835 in the past quarter
Ming-Hsiung Hsieh, Yun Yen & Minghui Hsieh
7/8/19
1 item of media coverage
Press/Media: Press / Media
Words from Our Executive Vice President, Dr. Ching-Hua Lo
7/8/19
15 items of media coverage
Press/Media: Press / Media